Evidence map›Paper›PMID 31243984›Full record

ArticleChemical research in toxicology2019

Identifying Compounds with Genotoxicity Potential Using Tox21 High-Throughput Screening Assays.

Jui-Hua Hsieh, Stephanie L Smith-Roe, Ruili Huang, Alexander Sedykh, Keith R Shockley, Scott S Auerbach, B Alex Merrick, Menghang Xia, Raymond R Tice, Kristine L Witt

Open access · greenAbstract read
In one paragraph

Article in Chemical research in toxicology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.4field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 37 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Prediction of Drug Targets based on In Vitro Activity Profiles Toward Drug Repurposing for Rare Diseases.IEEE International Conference on Bioinformatics and Biomedicine workshops. IEEE International Conference on Bioinformatics and Biomedicine · 2023
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. The expression of Phase II drug-metabolizing enzymes in human B-lymphoblastoid TK6 cells.Journal of environmental science and health. Part C, Toxicology and carcinogenesis · 2022
    Article
  16. Review
  17. Article
  18. Evaluation of pyrrolizidine alkaloid-induced genotoxicity using metabolically competent TK6 cell lines.Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association · 2020
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Jui-Hua HsiehKelly Government Solutions , Research Triangle Park , North Carolina 27709 , United States.ORCID 0000-0003-1620-1571
Stephanie L Smith-RoeDivision of the National Toxicology Program , National Institute of Environmental Health Sciences , Research Triangle Park , North Carolina 27709 , United States.
Ruili HuangNational Center for Advancing Translational Sciences , National Institutes of Health , Rockville , Maryland 20850 , United States.
Alexander SedykhSciome, LLC , Research Triangle Park , North Carolina 27709 , United States.
Keith R ShockleyDivision of Intramural Research , National Institute of Environmental Health Sciences , Research Triangle Park , North Carolina 27709 , United States.
Scott S AuerbachDivision of the National Toxicology Program , National Institute of Environmental Health Sciences , Research Triangle Park , North Carolina 27709 , United States.
B Alex MerrickDivision of the National Toxicology Program , National Institute of Environmental Health Sciences , Research Triangle Park , North Carolina 27709 , United States.
Menghang XiaNational Center for Advancing Translational Sciences , National Institutes of Health , Rockville , Maryland 20850 , United States.
Raymond R TiceRTice Consulting , Hillsborough , North Carolina 27278 , United States.
Kristine L WittDivision of the National Toxicology Program , National Institute of Environmental Health Sciences , Research Triangle Park , North Carolina 27709 , United States.
National Institute of Environmental Health Sciences · USNational Institutes of Health · USKelly Services (United States) · USResearch Triangle Park Foundation · US

Funding

Biomolecular Screening and Alternative Approaches for the National Toxicology ProgramZIAES103318 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI CASEY, WARREN · 2016 to 2021
$25.0M
Toxicology in the 21st Century Program (Tox21) - Systems ToxicologyZIATR000038 · NCATS · NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES · PI XIA, MENGHANG · 2015 to 2025
$5.7M
Intramural NIH HHS Z99 ES999999
6 · The paper itself

Abstract

Genotoxicity is a critical component of a comprehensive toxicological profile. The Tox21 Program used five quantitative high-throughput screening (qHTS) assays measuring some aspect of DNA damage/repair to provide information on the genotoxic potential of over 10 000 compounds. Included were assays detecting activation of p53, increases in the DNA repair protein ATAD5, phosphorylation of H2AX, and enhanced cytotoxicity in DT40 cells deficient in DNA-repair proteins REV3 or KU70/RAD54. Each assay measures a distinct component of the DNA damage response signaling network; >70% of active compounds were detected in only one of the five assays. When qHTS results were compared with results from three standard genotoxicity assays (bacterial mutation,

Indexed as

AnimalsCell Line, TumorChickensCHO CellsCricetulusDatabases, ChemicalDNADNA Breaks, Double-StrandedDNA RepairHigh-Throughput Screening AssaysHumansMutagensROC CurveDNAMutagens

Identifiers

PMID31243984
PMCPMC6740247
OpenAlexW2949776037

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.